Ambros Reinhard J. 4
4 · Rein Therapeutics, Inc. · Filed Jul 23, 2025
Insider Transaction Report
Form 4
Ambros Reinhard J.
Director
Transactions
- Award
Stock Option (right to buy)
2025-07-23+17,500→ 17,500 totalExercise: $1.55Exp: 2035-07-22→ Common Stock (17,500 underlying)
Footnotes (1)
- [F1]This option was granted on July 23, 2025. The shares underlying the option are scheduled to vest in full on the earlier of (i) July 23, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service.